Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa
In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a potential window for vertical transmission. Insights into HBV seroprevalence in the vulnerable HIV-infected group are important to drive improvements in surveillance, treatment and prevention.
We set out to implement a screening program for HBV among HIV-infected children and adolescents in Kimberley, South Africa. Our aims were to demonstrate that screening is fe...
- Publication status:
- Peer review status:
- Peer reviewed
- Copyright holder:
- Jooste et al
- Copyright date:
- Author(s) retain copyright; published by Elsevier under license. Open Access funded by the Wellcome Trust, available under a Creative Commons license.
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record